HCA Stock Analysis: Buy, Sell, or Hold?
HCA - HCA Healthcare, Inc.
$386.92
9.93 (2.63%)
▲
5d:
-0.78%
30d:
-1.44%
90d:
-21.77%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jul 24, 2026
30d
Smart Money Accumulation
None View Scanner →
Strength: 5.3/10
Get Alerted When HCA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: HCA trading at deep discount. Market pricing in -7.0% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: HCA trading at deep discount. Market pricing in -7.0% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$674.17
Based on 6.9% avg growth
INTRINSIC VALUE TODAY
$418.61
7.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HCA is currently trading at $386.92, which is considered slightly low relative to its 30-day fair value range of $368.26 to $404.97. From a valuation perspective, the stock is trading at a discount (Forward PE: 11.7) compared to its historical average (14.6). Remarkably, the market is currently pricing in an annual earnings decline of 7.0% over the next few years. This pessimistic expectation contrasts with the company's recent 10.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, HCA is in a strong downtrend. Immediate support is located at $365.68, while resistance sits at $399.38.
Market Sentiment: HCA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $503.57 (+30.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HCA is in a strong downtrend. Immediate support is located at $365.68, while resistance sits at $399.38.
Market Sentiment: HCA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $503.57 (+30.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$368.26 -
$404.97
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
90.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 30.1% below Wall St target ($503.57)
Trading Range Analysis
30-Day Trading Range
$368.26 -
$404.97
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$365.68
Resistance Level
$399.38
Current Trend
Strong Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.69
Wall Street Target
$503.57
(+30.1%)
Revenue Growth (YoY)
4.3%
Earnings Growth (YoY)
10.9%
Profit Margin
8.9%
Valuation Discount vs History
-7.0% cheaper
PE vs Historical
11.7 vs 14.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.0%
(market-implied from PE analysis)
1-Year Target
$359.84
(-7%)
2-Year Target
$334.65
(-14%)
3-Year Target
$311.22
(-20%)
3-Yr Target (if PE normalizes)
(PE: 12→15)
$388.80
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 9.8%)
$955.42
(+147%)
Base:
(SPY PE: 11.7, Growth: 9.8%)
$512.66
(+33%)
Bear:
(PE: 9.9, Growth: 9.8%)
$435.76
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (13x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 12.92 | Current EPS (TTM): $29.04
Bull Case
$470.49
(+25%)
Analyst growth 14.0%, PE expands to 14.2
Base Case
$427.72
(+14%)
Market implied 14.0%, PE stable at 12.9
Bear Case
$255.12
(-32%)
Severe decline -20.0%, PE contracts to 11.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.7 to 14.6
Stabilization Target:
$483.37
(+24.9%)
PE Expansion Potential:
+24.9%
Share & Embed Analysis
Last updated: June 23, 2026 5:56 PM ET
Data refreshes hourly during market hours. Next update: 6:56 PM
Data refreshes hourly during market hours. Next update: 6:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HCA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Michael R Mcalevey
SELL
1694 shares
2026-02-18
Ro Khanna
SELL
2026-02-17
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 57 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 53 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 53 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 60 HOLD |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 62 BUY |
Advanced HCA Option Strategies
Professional options setups generated by AI based on today's HCA price and gamma walls.
